Back to search

PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

Data up to Jan 2025

Published2002
Citations352
References51

Total Citations Per Year

Abstract

References (51)

The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation

1998 • 3,517 citations

Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor

1994 • 3,477 citations

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1994 • 3,367 citations

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1991 • 2,774 citations

The Mechanisms of Action of PPARs

2002 • 2,544 citations

Thalidomide is an inhibitor of angiogenesis.

1994 • 2,460 citations

PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development

1999 • 1,904 citations

PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL

1998 • 1,771 citations

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

2000 • 1,536 citations

Biological Action of Leptin as an Angiogenic Factor

1998 • 1,390 citations

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

2000 • 1,310 citations

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

2000 • 1,159 citations

PPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth

2001 • 1,147 citations

Macrophages and angiogenesis

1994 • 1,123 citations

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

2000 • 992 citations

Differentiation and reversal of malignant changes in colon cancer through PPARγ

1998 • 984 citations

Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors

2002 • 955 citations

Terminal Differentiation of Human Breast Cancer through PPARγ

1998 • 844 citations

Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1998 • 807 citations

Clinical Application of Antiangiogenic Therapy: Microvessel Density, What It Does and Doesn't Tell Us

2002 • 794 citations

Mechanism of action of taxol

1992 • 730 citations

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor

1997 • 655 citations

Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.

1998 • 599 citations

Centrosome defects and genetic instability in malignant tumors.

1998 • 583 citations

Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in Vivo

1999 • 527 citations

Modulation of Vascular Inflammation In Vitro and In Vivo by Peroxisome Proliferator–Activated Receptor-γ Activators

2000 • 504 citations

Identification of an Inhibitor of Neovascularization from Cartilage

1990 • 481 citations

Maspin is an angiogenesis inhibitor

2000 • 463 citations

Endothelial Cell Apoptosis Induced by the Peroxisome Proliferator-activated Receptor (PPAR) Ligand 15-Deoxy-Δ12,14-prostaglandin J2

1999 • 440 citations

Molecular Cloning, Expression and Characterization of Human Peroxisome Proliferator Activated Receptors γ1 and γ2

1996 • 387 citations

PPARγ Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor Type-1 Expression

1999 • 370 citations

Degradation of the Peroxisome Proliferator-activated Receptor γ Is Linked to Ligand-dependent Activation

2000 • 360 citations

Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.

1999 • 317 citations

Metastatic Model for Human Prostate Cancer Using Orthotopic Implantation in Nude Mice

1992 • 310 citations

Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation.

2001 • 304 citations

Angiogenesis-dependent diseases

2001 • 294 citations

Troponin I is present in human cartilage and inhibits angiogenesis

1999 • 221 citations

Ligands for Peroxisome Proliferator-Activated Receptor γ Inhibit Growth and Induce Apoptosis of Human Papillary Thyroid Carcinoma Cells

2001 • 220 citations

Transforming Growth Factor-α Prevents Detachment-induced Inhibition of c-Src Kinase Activity, Bcl-XLDown-regulation, and Apoptosis of Intestinal Epithelial Cells

2001 • 202 citations

Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.

2000 • 180 citations

Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy.

2000 • 141 citations

The Chick Embryo Chorioallantoic Membrane as a Model for in vivo Research on Anti-Angiogenesis

2000 • 124 citations

Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP).

1994 • 89 citations

Role of Peroxisome Proliferator-Activated Receptor γ and Its Ligands in Non-Neoplastic and Neoplastic Human Urothelial Cells

2001 • 84 citations

Ligands for Peroxisome Proliferator-Activated Receptor Inhibit Growth and Induce Apoptosis of Human Papillary Thyroid Carcinoma Cells

2001 • 78 citations

Aquaporins and the respiratory system: advice for a lung investigator

2000 • 78 citations

PPARgamma ligands as modulators of inflammatory and catabolic responses in arthritis. An overview.

2002 • 78 citations

Magnitude of Peroxisome Proliferator-Activated Receptor-γ Activation is Associated with Important and Seemingly opposite Biological Responses in Breast Cancer Cells

2001 • 70 citations

Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer.

2001 • 54 citations

Systemic exposure to rosiglitazone is unaltered by food

1999 • 51 citations

Effects of Troglitazone and Pioglitazone on Cytokine-Mediated Endothelial Cell Proliferation In Vitro

1998 • 41 citations

Cited By (0)

Loading...
PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis (2002) – Journal of Clinical Investigation | Metascience Observatory Explorer